Abstract
Oridonin is one of the ent-kaurane diterpenes that have been studied extensively for various bioactivities. In an effort to expand natural scaffold-based library as anticancer agents, we have designed and synthesised a number of novel oridonin derivatives and evaluated their bioactivities on a panel of human cancer cell lines (HCT116, A375, MCF-7, HepG2, and A549). Compound 4b bearing a 4-fluorophenyl moiety was found to be the most active compound with an IC50 value of 0.3 μM against MCF-7 cells, which was 7.4-fold more active than oridonin. This study could provide some insightful information for further synthesis of oridonin derivatives as anticancer agents.
| Original language | English |
|---|---|
| Pages (from-to) | 550-558 |
| Number of pages | 9 |
| Journal | Natural Product Research |
| Volume | 39 |
| Issue number | 3 |
| Early online date | 30 Oct 2023 |
| DOIs | |
| Publication status | Published - 1 Feb 2025 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
User-Defined Keywords
- anticancer
- cytotoxicity
- derivatives
- ent-kaurane diterpenoid
- Oridonin
Fingerprint
Dive into the research topics of 'Design and synthesis of oridonin derivatives as cytotoxic agents'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver